1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TG THERAPEUTICS INC
TG Therapeutics Inc XNAS: TGTX

TG Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Falling Comet
about

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Dr...

Read More
32.24 -1.02 (-3.07%)
30.64% Fall from 52W High
1.8M
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Affordable Valuation
50.5 / 100
Momentum Score
Technically Bearish
34.9 / 100
Falling Comet These stocks are with medium quality with average financials but with good valuation score. However, their weak technical aspects reduces the investor interest. View Similar Embed DVM
Analyst Price Target
44
1Yr Price target upside is 37%
7 analysts

18

S

7

W

1

O

3

T

SWOT Analysis

TG Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..